bupivacaine hci and epinephrine
Generic: bupivacaine hci and epinephrine
Labeler: hf acquisition co llc, dba healthfirstDrug Facts
Product Profile
Brand Name
bupivacaine hci and epinephrine
Generic Name
bupivacaine hci and epinephrine
Labeler
hf acquisition co llc, dba healthfirst
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
bupivacaine hydrochloride 5 mg/mL, epinephrine bitartrate .005 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51662-1399
Product ID
51662-1399_10328ddf-6e3b-c9e0-e063-6294a90a52ed
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA070968
Listing Expiration
2026-12-31
Marketing Start
2019-12-09
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516621399
Hyphenated Format
51662-1399
Supplemental Identifiers
UPC
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupivacaine hci and epinephrine (source: ndc)
Generic Name
bupivacaine hci and epinephrine (source: ndc)
Application Number
ANDA070968 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/mL
- .005 mg/mL
Packaging
- 50 mL in 1 VIAL, MULTI-DOSE (51662-1399-1)
- 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1399-2) / 50 mL in 1 VIAL, MULTI-DOSE
- 25 POUCH in 1 CASE (51662-1399-3) / 1 VIAL, MULTI-DOSE in 1 POUCH / 50 mL in 1 VIAL, MULTI-DOSE
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["PERINEURAL"], "spl_id": "10328ddf-6e3b-c9e0-e063-6294a90a52ed", "openfda": {"upc": ["0363323463014"], "unii": ["7TQO7W3VT8", "30Q7KI53AK"], "spl_set_id": ["99516811-56e2-9c8a-e053-2a95a90ac9cb"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL, MULTI-DOSE (51662-1399-1)", "package_ndc": "51662-1399-1", "marketing_start_date": "20191209"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 POUCH (51662-1399-2) / 50 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1399-2", "marketing_start_date": "20210126"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1399-3) / 1 VIAL, MULTI-DOSE in 1 POUCH / 50 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1399-3", "marketing_start_date": "20210126"}], "brand_name": "BUPIVACAINE HCI AND EPINEPHRINE", "product_id": "51662-1399_10328ddf-6e3b-c9e0-e063-6294a90a52ed", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Catecholamine [EPC]", "Catecholamines [CS]", "Local Anesthesia [PE]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1399", "generic_name": "BUPIVACAINE HCI AND EPINEPHRINE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPIVACAINE HCI AND EPINEPHRINE", "active_ingredients": [{"name": "BUPIVACAINE HYDROCHLORIDE", "strength": "5 mg/mL"}, {"name": "EPINEPHRINE BITARTRATE", "strength": ".005 mg/mL"}], "application_number": "ANDA070968", "marketing_category": "ANDA", "marketing_start_date": "20191209", "listing_expiration_date": "20261231"}